Dendritic cells in Leishmania infection
- PMID: 15596127
- DOI: 10.1016/j.micinf.2004.10.004
Dendritic cells in Leishmania infection
Abstract
Dendritic cells (DCs) are key elements of the immune system, which function as sentinel in the periphery and alert T lymphocytes about the type of invading antigen and address their polarisation, in order to mount an efficacious immune response. Leishmania spp. are parasitic protozoa which may cause severe disease in humans and domestic animals. In this work, the main studies concerning the role of DCs in Leishmania infection are reviewed, in both the murine and human models. In particular, the importance of the genetic status of the hosts and of the different Leishmania species in modulating DC-mediated immune response is examined. In addition, different approaches of DC-based vaccination against experimental leishmaniasis, which could have important future applications, are summarised.
Similar articles
-
Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis.Immunobiology. 2001 Dec;204(5):659-66. doi: 10.1078/0171-2985-00105. Immunobiology. 2001. PMID: 11846231 Review.
-
Vaccination with TAT-antigen fusion protein induces protective, CD8(+) T cell-mediated immunity against Leishmania major.J Invest Dermatol. 2010 Nov;130(11):2602-10. doi: 10.1038/jid.2010.171. Epub 2010 Jun 24. J Invest Dermatol. 2010. PMID: 20574442 Free PMC article.
-
Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.Hum Gene Ther. 1998 Sep 1;9(13):1899-907. doi: 10.1089/hum.1998.9.13-1899. Hum Gene Ther. 1998. PMID: 9741428
-
Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.Vaccine. 2004 Sep 28;22(29-30):3865-76. doi: 10.1016/j.vaccine.2004.04.015. Vaccine. 2004. PMID: 15364433
-
Challenges and perspectives in vaccination against leishmaniasis.Parasitol Int. 2009 Dec;58(4):319-24. doi: 10.1016/j.parint.2009.07.013. Epub 2009 Aug 19. Parasitol Int. 2009. PMID: 19698801 Review.
Cited by
-
Immunoregulation in human American leishmaniasis: balancing pathology and protection.Parasite Immunol. 2014 Aug;36(8):367-76. doi: 10.1111/pim.12100. Parasite Immunol. 2014. PMID: 24471648 Free PMC article. Review.
-
Clonality testing in the lymph nodes from dogs with lymphadenomegaly due to Leishmania infantum infection.PLoS One. 2019 Dec 16;14(12):e0226336. doi: 10.1371/journal.pone.0226336. eCollection 2019. PLoS One. 2019. PMID: 31841533 Free PMC article.
-
Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.PLoS Pathog. 2013 Oct;9(10):e1003699. doi: 10.1371/journal.ppat.1003699. Epub 2013 Oct 24. PLoS Pathog. 2013. PMID: 24204259 Free PMC article.
-
Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects.Front Immunol. 2014 Jun 26;5:296. doi: 10.3389/fimmu.2014.00296. eCollection 2014. Front Immunol. 2014. PMID: 25183962 Free PMC article. Review.
-
Purinergic signaling and infection by Leishmania: A new approach to evasion of the immune response.Biomed J. 2016 Aug;39(4):244-250. doi: 10.1016/j.bj.2016.08.004. Epub 2016 Sep 21. Biomed J. 2016. PMID: 27793266 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous